Denali Therapeutics Inc. (NASDAQ: DNLI) reported Q1 EPS of ($0.69), $0.03 worse than the analyst estimate of ($0.66).

For earnings history and earnings-related data on Denali Therapeutics Inc. (DNLI) click here.